37 scientific business analyst jobs found

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

The Executive Director, Biostatistics (CDU-Biostatistics Head, Internal Medicine) leads the statistical team for the assigned Clinical Development Unit, in partnership with leadership within Biostatistics and Data Management, Clinical Sciences, Regulatory Affairs, Development Operations and Development Program Management, R&pD, and other key functions at Regeneron.  The incumbent is an experienced leader, passionate drug developer, skilled manager and mentor, and an accomplished statistician with a strong ability to communicate technical concepts to non-statisticians.   The Executive Director is responsible for providing critical strategic input to the development programs within the CDU, from pre-IPA through regulatory approval and post-marketing, and builds and empowers teams to ensure the successful execution on our pipeline.  The Executive Director drives the development of appropriate phase-specific statistical strategies are developed and implemented, such as...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

The Associate Director, Strategic Analysis will be responsible for formulating and articulating insights about unmet medical needs and the external landscape to help advise key research, clinical development and commercialization decisions for the Internal Medicine therapeutic focus area.  You will have input on assets spanning the Internal Medicine portfolio, and in partnership with senior leaders, will influence strategic alignment around key development decisions including: advancing the development of assets; indication selection; clinical trial design; and regulatory path. This high visibility role requires strong communication skills and the ability to distill complex insights to senior leaders throughout the organization, including the executive team. At Regeneron, you will be an important member of an innovative team where your contributions will help drive the success of the company.  This is a great opportunity to support the strategic roadmap for one of our most...

The Field Director, MSL (FD) plans, directs, coordinates and supports the activities of the Medical Science Liaisons (MSLs) within a designated geographic region to achieve scientific and business objectives within Dermatology Medical Affairs. This includes, but is not limited to, coaching and mentoring for a designated number of medical level professionals (MSLs) in a therapeutic region. The FD reports to the National Director and works cross-functionally within Medical Affairs to identify, develop, implement, and monitor MSL strategies and tactics. Duties include strategic planning, financial management, personnel management, performance management process, regional awareness and expertise, data analysis, generation of metrics, material management, professional development, training, support, and execution of organizational goals and objectives. Responsibilities: People Leadership and Development: Provide coaching, mentoring and guidance that is consistent and timely to MSLs...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

The Field Director, MSL (FD) plans, directs, coordinates and supports the activities of the Medical Science Liaisons (MSLs) within a designated geographic region to achieve scientific and business objectives within Dermatology Medical Affairs. This includes, but is not limited to, coaching and mentoring for a designated number of medical level professionals (MSLs) in a therapeutic region. The FD reports to the National Director and works cross-functionally within Medical Affairs to identify, develop, implement, and monitor MSL strategies and tactics. Duties include strategic planning, financial management, personnel management, performance management process, regional awareness and expertise, data analysis, generation of metrics, material management, professional development, training, support, and execution of organizational goals and objectives. Responsibilities: People Leadership and Development: Provide coaching, mentoring and guidance that is consistent and timely to MSLs...

The Field Director, MSL (FD) plans, directs, coordinates and supports the activities of the Medical Science Liaisons (MSLs) within a designated geographic region to achieve scientific and business objectives within Dermatology Medical Affairs. This includes, but is not limited to, coaching and mentoring for a designated number of medical level professionals (MSLs) in a therapeutic region. The FD reports to the National Director and works cross-functionally within Medical Affairs to identify, develop, implement, and monitor MSL strategies and tactics. Duties include strategic planning, financial management, personnel management, performance management process, regional awareness and expertise, data analysis, generation of metrics, material management, professional development, training, support, and execution of organizational goals and objectives. Responsibilities People Leadership and Development: Provide coaching, mentoring and guidance that is consistent and timely to MSLs...

The Field Director, MSL (FD) plans, directs, coordinates and supports the activities of the Medical Science Liaisons (MSLs) within a designated geographic region to achieve scientific and business objectives within Dermatology Medical Affairs. This includes, but is not limited to, coaching and mentoring for a designated number of medical level professionals (MSLs) in a therapeutic region. The FD reports to the National Director and works cross-functionally within Medical Affairs to identify, develop, implement, and monitor MSL strategies and tactics. Duties include strategic planning, financial management, personnel management, performance management process, regional awareness and expertise, data analysis, generation of metrics, material management, professional development, training, support, and execution of organizational goals and objectives. Responsibilities People Leadership and Development: Provide coaching, mentoring and guidance that is consistent and timely to MSLs...

The Field Director, MSL (FD) plans, directs, coordinates and supports the activities of the Medical Science Liaisons (MSLs) within a designated geographic region to achieve scientific and business objectives within Dermatology Medical Affairs. This includes, but is not limited to, coaching and mentoring for a designated number of medical level professionals (MSLs) in a therapeutic region. The FD reports to the National Director and works cross-functionally within Medical Affairs to identify, develop, implement, and monitor MSL strategies and tactics. Duties include strategic planning, financial management, personnel management, performance management process, regional awareness and expertise, data analysis, generation of metrics, material management, professional development, training, support, and execution of organizational goals and objectives. Responsibilities People Leadership and Development: Provide coaching, mentoring and guidance that is consistent and timely to MSLs...

The Field Director, MSL (FD) plans, directs, coordinates and supports the activities of the Medical Science Liaisons (MSLs) within a designated geographic region to achieve scientific and business objectives within Dermatology Medical Affairs. This includes, but is not limited to, coaching and mentoring for a designated number of medical level professionals (MSLs) in a therapeutic region. The FD reports to the National Director and works cross-functionally within Medical Affairs to identify, develop, implement, and monitor MSL strategies and tactics. Duties include strategic planning, financial management, personnel management, performance management process, regional awareness and expertise, data analysis, generation of metrics, material management, professional development, training, support, and execution of organizational goals and objectives. Responsibilities People Leadership and Development: Provide coaching, mentoring and guidance that is consistent and timely to MSLs...

The Field Director, MSL (FD) plans, directs, coordinates and supports the activities of the Medical Science Liaisons (MSLs) within a designated geographic region to achieve scientific and business objectives within Dermatology Medical Affairs. This includes, but is not limited to, coaching and mentoring for a designated number of medical level professionals (MSLs) in a therapeutic region. The FD reports to the National Director and works cross-functionally within Medical Affairs to identify, develop, implement, and monitor MSL strategies and tactics. Duties include strategic planning, financial management, personnel management, performance management process, regional awareness and expertise, data analysis, generation of metrics, material management, professional development, training, support, and execution of organizational goals and objectives. Responsibilities People Leadership and Development: Provide coaching, mentoring and guidance that is consistent and timely to MSLs...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com . As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit. Job Function: Pharmaceutical Sales Job Sub Function: Sales – Neuroscience (Commission) Job Category: People Leader...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...